U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230457) titled 'Plasma MTB cfDNA Before Bronchoscopy' on Sept. 30.
Brief Summary: Tuberculosis (TB) remains a major global health challenge, affecting over 10 million people annually. Hong Kong carries an intermediate TB burden, with ~3,200 new cases reported yearly. Pulmonary TB (PTB), the most common form, presents diagnostic difficulties. Traditional methods like sputum smear and culture often fail in patients unable to produce adequate samples, necessitating bronchoscopy to collect bronchoalveolar lavage (BAL) for mycobacterial testing.
These limitations pose risks for patients and strain healthcare systems. Bronchoscopy is invasive, resource-...